Breast cancer brain metastases express the sodium iodide symporter

Journal of Neuro-Oncology

Volumn 96, Issue 3, 2010, Pages 331-336

  Renier, Corinne ^a   Vogel, Hannes ^a   Offor, Onyinye ^a   Yao, Chen ^a,b   Wapnir, Irene ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Breast cancer brain metastases; Sodium iodide symporter

Indexed keywords

C PEPTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; POLYCLONAL ANTIBODY; PROGESTERONE RECEPTOR; RADIOACTIVE IODINE; SODIUM IODIDE SYMPORTER;

ARTICLE; BRAIN METASTASIS; BREAST CANCER; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN EXPRESSION;

BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SYMPORTERS;

EID: 75049083184     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9971-8     Document Type: Article

References (44)

1. YT Lee 1983 Breast carcinoma: pattern of metastasis at autopsy J Surg Oncol 23 175 180 10.1002/jso.2930230311 1:STN:280:DyaL3s3ktlWhtw%3D%3D 6345937
2. EM Pelletier B Shim S Goodman MM Amonkar 2008 Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis Breast Cancer Res Treat 108 297 305 10.1007/s10549-007-9601-0 17577662 (Pubitemid 351311367)
3. D Crivellari O Pagani A Veronesi D Lombardi F Nole B Thurlimann D Hess M Borner J Bauer G Martinelli R Graffeo C Sessa A Goldhirsch 2001 High incidence of central nervous system involvement in patients with metastatic or locallyadvanced breast cancer treated with epirubicin and docetaxel Ann Oncol 12 353 356 10.1023/A:1011132609055 1:STN:280:DC%2BD3MrhsFCjug%3D%3D 11332148 (Pubitemid 32288692)
4. JS Barnholtz-Sloan AE Sloan FG Davis FD Vigneau P Lai RE Sawaya 2004 Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system J Clin Oncol 22 2865 2872 10.1200/JCO.2004.12.149 10.1200/JCO.2004.12.149 15254054 (Pubitemid 41079905)
5. EH Romond EA Perez J Bryant VJ Suman CE Geyer Jr NE Davidson E Tan-Chiu S Martino S Paik PA Kaufman SM Swain TM Pisansky L Fehrenbacher LA Kutteh VG Vogel DW Visscher G Yothers RB Jenkins AM Brown SR Dakhil EP Mamounas WL Lingle PM Klein JN Ingle N Wolmark 2005 Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 1673 1684 10.1056/NEJMoa052122 1:CAS:528:DC%2BD2MXhtFansr3F 16236738 (Pubitemid 41464706)
6. SS Lee JH Ahn MK Kim SJ Sym G Gong SD Ahn SB Kim WK Kim 2008 Brain metastases in breast cancer: prognostic factors and management Breast Cancer Res Treat 111 523 530 10.1007/s10549-007-9806-2 17990100
7. JC Bendell SM Domchek HJ Burstein L Harris J Younger I Kuter C Bunnell M Rue R Gelman E Winer 2003 Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma Cancer 97 2972 2977 10.1002/cncr.11436 12784331 (Pubitemid 36676250)
8. E Shmueli N Wigler M Inbar 2004 Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment Eur J Cancer 40 379 382 10.1016/j.ejca.2003.09.018 1:CAS:528:DC%2BD2cXmvFCqtQ%3D%3D 14746856 (Pubitemid 38121275)
9. Z Gabos R Sinha J Hanson N Chauhan J Hugh JR Mackey B Abdulkarim 2006 Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer J Clin Oncol 24 5658 5663 10.1200/JCO.2006.07.0250 10.1200/JCO.2006.07.0250 1:CAS:528:DC%2BD2sXhtVChsrc%3D 17102066 (Pubitemid 46631306)
10. NU Lin EP Winer 2007 Brain metastases: the HER2 paradigm Clin Cancer Res 13 1648 1655 10.1158/1078-0432.CCR-06-2478 10.1158/1078-0432.CCR-06-2478 1:CAS:528:DC%2BD2sXivV2gtro%3D 17363517 (Pubitemid 46952930)
11. NU Lin V Dieras D Paul D Lossignol C Christodoulou HJ Stemmler H Roche MC Liu R Greil E Ciruelos S Loibl S Gori A Wardley D Yardley A Brufsky JL Blum SD Rubin B Dharan K Steplewski D Zembryki C Oliva D Roychowdhury P Paoletti EP Winer 2009 Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer Clin Cancer Res 15 1452 1459 10.1158/1078-0432.CCR-08-1080 1:CAS:528:DC%2BD1MXitVOktLo%3D 19228746
12. G Dai O Levy N Carrasco 1996 Cloning and characterization of the thyroid iodide transporter Nature 379 458 460 10.1038/379458a0 1:CAS:528: DyaK28XovVagtw%3D%3D 8559252 (Pubitemid 26039527)
13. UH Tazebay IL Wapnir O Levy O Dohan LS Zuckier QH Zhao HF Deng PS Amenta S Fineberg RG Pestell N Carrasco 2000 The mammary gland iodide transporter is expressed during lactation and in breast cancer Nat Med 6 871 878 10.1038/78630 1:CAS:528:DC%2BD3cXlsFamt7o%3D 10932223 (Pubitemid 30644744)
14. PA Smanik Q Liu TL Furminger K Ryu S Xing EL Mazzaferri SM Jhiang 1996 Cloning of the human sodium lodide symporter Biochem Biophys Res Commun 226 339 345 10.1006/bbrc.1996.1358 1:CAS:528:DyaK28Xls1yis7g%3D 8806637 (Pubitemid 26331906)
15. C Spitzweg AB Dietz MK O'Connor ER Bergert DJ Tindall CY Young JC Morris 2001 In vivo sodium iodide symporter gene therapy of prostate cancer Gene Ther 8 1524 1531 10.1038/sj.gt.3301558 1:CAS:528:DC%2BD3MXotVWisLY%3D 11704812 (Pubitemid 33061890)
16. IL Wapnir M van de Rijn K Nowels PS Amenta K Walton K Montgomery RS Greco O Dohan N Carrasco 2003 Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections J Clin Endocrinol Metab 88 1880 1888 10.1210/jc.2002-021544 1:CAS:528:DC%2BD3sXjtFCltLk%3D 12679487 (Pubitemid 36623418)
17. M Schlumberger M Tubiana F De Vathaire C Hill P Gardet JP Travagli P Fragu J Lumbroso B Caillou C Parmentier 1986 Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma J Clin Endocrinol Metab 63 960 967 10.1210/jcem-63-4-960 1:STN:280: DyaL28zgsVymtw%3D%3D 3745409
18. NA Samaan PN Schultz TP Haynie NG Ordonez 1985 Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients J Clin Endocrinol Metab 60 376 380 10.1210/jcem-60-2-376 1:STN:280: DyaL2M%2FotVersg%3D%3D 3965495
19. Mazzaferri E (1996) Radioiodine and other treatment and outcomes. In: RD Blau (ed) Werner and Ingbar's the thyroid: A fundamental and clinical text. JB Lipincott, Philadelphia, pp 904-929
20. C Renier C Yao M Goris M Ghosh K Nowles SS Gambhir I Wapnir 2009 Endogenous NIS expression in triple negative breast cancers Ann Surg Oncol 16 962 968 10.1245/s10434-008-0280-9 19184238
21. - symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid Clin Cancer Res 10 4294 4302 10.1158/1078-0432.CCR-04-0074 1:CAS:528:DC%2BD2cXlsVWlsrY%3D 15240514 (Pubitemid 38878866)
22. RB Mandell LZ Mandell CJ Link Jr 1999 Radioisotope concentrator gene therapy using the sodium/iodide symporter gene Cancer Res 59 661 668 1:CAS:528:DyaK1MXhtV2rtb0%3D 9973215
23. T Kogai Y Kanamoto LH Che K Taki F Moatamed JJ Schultz GA Brent 2004 Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodide uptake in mouse breast cancer models Cancer Res 64 415 422 10.1158/0008-5472.CAN-03-2285 1:CAS:528:DC%2BD2cXkslyqtg%3D%3D 14729653 (Pubitemid 38114126)
24. M Ghosh SS Gambhir A De K Nowels M Goris I Wapnir 2006 Bioluminescent monitoring of NIS-mediated (131)I ablative effects in MCF-7 xenografts Mol Imaging 5 76 84 16954021
25. T Kogai K Taki GA Brent 2006 Enhancement of sodium/iodide symporter expression in thyroid and breast cancer Endocr Relat Cancer 13 797 826 10.1677/erc.1.01143 1:CAS:528:DC%2BD28XhtlequrzI 16954431 (Pubitemid 44763258)
26. D Palmieri JL Bronder JM Herring T Yoneda RJ Weil AM Stark R Kurek E Vega-Valle L Feigenbaum D Halverson AO Vortmeyer SM Steinberg K Aldape PS Steeg 2007 Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain Cancer Res 67 4190 4198 10.1158/0008-5472.CAN-06-3316 1:CAS:528:DC%2BD2sXltVyrs78%3D 17483330 (Pubitemid 46815065)
27. NU Lin JR Bellon EP Winer 2004 CNS metastases in breast cancer J Clin Oncol 22 3608 3617 10.1200/JCO.2004.01.175 15337811 (Pubitemid 41103668)
28. DG Hicks SM Short NL Prescott SM Tarr KA Coleman BJ Yoder JP Crowe TK Choueiri AE Dawson GT Budd RR Tubbs G Casey RJ Weil 2006 Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR Am J Surg Pathol 30 1097 1104 16931954
29. GA Viani MS Castilho JV Salvajoli AC Pellizzon PE Novaes FS Guimaraes MA Conte RC Fogaroli 2007 Whole brain radiotherapy for brain metastases from breast cancer: Estimation of survival using two stratification systems BMC Cancer 7 53 10.1186/1471-2407-7-53 17386108 (Pubitemid 46566604)
30. PY Wen JS Loeffler 2000 Brain metastases Curr Treat Options Oncol 1 447 458 10.1007/s11864-000-0072-3 1:STN:280:DC%2BD38zhsFSqtg%3D%3D 12057152
31. H Kusuhara Y Sugiyama 2005 Active efflux across the blood-brain barrier: role of the solute carrier family NeuroRx 2 73 85 10.1602/neurorx.2.1.73 15717059 (Pubitemid 40128028)
32. F Girardin 2006 Membrane transporter proteins: a challenge for CNS drug development Dialogues Clin Neurosci 8 311 321 17117613
33. W Boogerd VW Vos AA Hart G Baris 1993 Brain metastases in breast cancer; natural history, prognostic factors and outcome J Neurooncol 15 165 174 10.1007/BF01053937 1:STN:280:DyaK3s3os1KmtQ%3D%3D 8509821
34. AC Chiu ES Delpassand SI Sherman 1997 Prognosis and treatment of brain metastases in thyroid carcinoma J Clin Endocrinol Metab 82 3637 3642 10.1210/jc.82.11.3637 1:CAS:528:DyaK2sXnt1Cntb8%3D 9360519
35. M Salvati A Frati G Rocchi R Masciangelo A Antonaci FM Gagliardi R Delfini 2001 Single brain metastasis from thyroid cancer: report of twelve cases and review of the literature J Neurooncol 51 33 40 10.1023/A:1006468527935 1:STN:280:DC%2BD3M3ltFKgsA%3D%3D 11349878 (Pubitemid 32321899)
36. FL Datz 1986 Cerebral edema following iodine-131 therapy for thyroid carcinoma metastatic to the brain J Nucl Med 27 637 640 1:STN:280: DyaL283is1KntA%3D%3D 3712081
37. MJ Schlumberger 1998 Papillary and follicular thyroid carcinoma N Engl J Med 338 297 306 10.1056/NEJM199801293380506 1:STN:280:DyaK1c%2Fpt1SktA%3D%3D 9445411 (Pubitemid 28065257)
38. C Riedel O Levy N Carrasco 2001 Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin J Biol Chem 276 21458 21463 10.1074/jbc.M100561200 1:CAS:528:DC%2BD3MXksFGlurg%3D 11290744
39. S Unterholzner MJ Willhauck N Cengic M Schutz B Goke JC Morris C Spitzweg 2006 Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells J Clin Endocrinol Metab 91 69 78 10.1210/jc.2005-0779 1:CAS:528:DC%2BD28Xms1ahtQ%3D%3D 16234306 (Pubitemid 43069120)
40. KA Knostman JA McCubrey CD Morrison Z Zhang CC Capen SM Jhiang 2007 PI3 K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer BMC Cancer 7 137 10.1186/1471-2407-7-137 17651485 (Pubitemid 47354239)
41. E Ohashi T Kogai H Kagechika GA Brent 2009 Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells Cancer Res 69 3443 3450 10.1158/0008-5472.CAN-08-3234 1:CAS:528:DC%2BD1MXksV2htr4%3D 19351850
42. JY Cho DH Shen W Yang B Williams TL Buckwalter KM La Perle G Hinkle R Pozderac R Kloos HN Nagaraja RF Barth SM Jhiang 2002 In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas Gene Ther 9 1139 1145 10.1038/sj.gt.3301787 1:CAS:528:DC%2BD38XlvFylsbw%3D 12170377 (Pubitemid 34993936)
43. G Sgouros KS Kolbert A Sheikh KS Pentlow EF Mun A Barth RJ Robbins SM Larson 2004 Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software J Nucl Med 45 1366 1372 1:CAS:528:DC%2BD2cXnsFSmu70%3D 15299063
44. O Dohan A De la Vieja V Paroder C Riedel M Artani M Reed CS Ginter N Carrasco 2003 The sodium/iodide symporter (NIS): characterization, regulation, and medical significance Endocr Rev 24 48 77 10.1210/er.2001-0029 1:CAS:528:DC%2BD3sXhslOgsb0%3D 12588808 (Pubitemid 36223279)